Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Neonatal Encephalopathy Secondary to Birth Asphyxia
NCT06098833Phase 2Recruiting
- Start
- Jul 2024
- Primary completion
- Oct 2030
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ASP-001 in neonatal encephalopathy (NE). Started Jul 2024; status: recruiting.
02
Drugs
ASP-001
03
Conditions
neonatal encephalopathy (NE)
Beyond the preview
Go deeper on NCT06098833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06098833.